Prevalence of atrial fibrillation in the general population of Japan: An analysis based on periodic health examination

International Journal of Cardiology

Volumn 137, Issue 2, 2009, Pages 102-107

  Inoue, Hiroshi ^a   Fujiki, Akira ^a   Origasa, Hideki ^a   Ogawa, Satoshi ^b   Okumura, Ken ^c   Kubota, Isao ^d   Aizawa, Yoshifusa ^e   Yamashita, Takeshi ^f   Atarashi, Hirotsugu ^g   Horie, Minoru ^h   Ohe, Tohru ⁱ   Doi, Yoshinori ^j   Shimizu, Akihiko ^k   Chishaki, Akiko ^l   Saikawa, Tetsunori ^m   Yano, Katsusuke ⁿ   Kitabatake, Akira ^o   Mitamura, Hideo ^p   Kodama, Itsuo ^q   Kamakura, Shiro ^r  

^a UNIVERSITY OF TOYAMA   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

^d YAMAGATA UNIVERSITY   (Japan)

^e NIIGATA UNIVERSITY   (Japan)

^f THE CARDIOVASCULAR INSTITUTE   (Japan)

^g NIPPON MEDICAL SCHOOL   (Japan)

^h SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

ⁱ OKAYAMA UNIVERSITY   (Japan)

^j KOCHI UNIVERSITY   (Japan)

^k YAMAGUCHI UNIVERSITY   (Japan)

^l KYUSHU UNIVERSITY   (Japan)

^m OITA UNIVERSITY   (Japan)

ⁿ NAGASAKI UNIVERSITY   (Japan)

^o HOKKAIDO UNIVERSITY   (Japan)

^p SAISEIKAI CENTRAL HOSPITAL   (Japan)

^q NAGOYA UNIVERSITY   (Japan)

^r NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

more..

Author keywords

Atrial fibrillation; Epidemiology; Prevalence

Indexed keywords

ADULT; AGE; AGED; ARTICLE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PERIODIC MEDICAL EXAMINATION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PHYSICAL EXAMINATION; POPULATION GROUPS; PREVALENCE; SEX FACTORS;

EID: 70349452199     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.06.029     Document Type: Article

References (35)

1. Kannel W.B., Wolf P.A., Benjamin E.J., and Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82 (1998) 2N-9N
2. Kannel W.B., Abbott R.D., Savage D.D., and McNamara P.M. Epidemiologic features of chronic atrial fibrillation: the Framingham Study. N Engl J Med 306 (1982) 1018-1022
3. Krahn A.D., Manfreda J., Tate R.B., Mathewson F.A.L., and Cuddy T.E. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study. Am J Med 98 (1995) 476-484
4. Dries D.L., Exner D.V., Gersh B.J., Domanski M.J., Waclawiw M.A., and Stevenson L.W. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. J Am Coll Cardiol 32 (1998) 695-703
5. Vidaillet H., Granada J.F., Chyou P.H., et al. A population-based study of mortality among patients with atrial fibrillation or flutter. Am J Med 113 (2002) 365-370
6. Wolf P.A., Abbott R.D., and Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22 (1991) 983-988
7. Furberg C.D., Psaty B.M., Manolio T.A., Gardin J.M., Smith V.E., and Rautaharju PM for the CHS Collaborator Research Group. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 74 (1994) 236-241
8. Feinberg W.M., Blackshear J.L., Laupacis A., Kronmal R., and Hart R.G. Prevalence, age distribution, and gender of patients with atrial fibrillation. Arch Intern Med 155 (1995) 469-473
9. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285 (2001) 2370-2375
10. Majeed A., Moser K., and Carroll K. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database. Heart 86 (2001) 284-288
11. Benjamin E.J., Levy D., Vaziri S.M., D'Agostino R.B., Belanger A.J., and Wolf P.A. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271 (1994) 840-844
12. Djousse L., Levy D., Benjamin E.J., et al. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham study. Am J Cardiol 93 (2004) 710-713
13. Kubo M., Kiyohara Y., Kato I., et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community. The Hisayama Study. Stroke 34 (2003) 2349-2354
14. Miyamatsu N., et al., for the NIPPON DATA80 Research Group. Different effects of blood pressure on mortality from stroke subtypes depending on BMI levels: a 19-year cohort study in the Japanese general population - NIPPON DATA80. J Hum Hypertens 19 (2005) 285-291
15. Wolf-Maier K., Cooper R.S., Banegas J.R., et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289 (2003) 2363-2369
16. Hajjar I., and Kotchen T.A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 290 (2003) 199-206
17. Sekikawa A., Satoh T., Hayakawa T., Ueshima H., and Kuller L.H. Coronary heart disease mortality among men aged 35-44 years by prefecture in Japan in 1995-1999 compared with that among white men aged 35-44 by State in the United States in 1995-1998. Vital statistics data in recent birth cohorts. Jpn Circ J 65 (2001) 887-892
18. Yokoyama M., et al., for the Japan EPA Lipid Intervention Study Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369 (2007) 1090-1098
19. GISSI-Prevenzione Investigators (Gruppe Italiano per lo Studio della Sopravvienza nell'infarto miocardico). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354 (1999) 447-455
20. Nakayama T., Date C., Yokoyama T., Yoshiike N., Yamaguchi M., and Tanaka H. A 15.5-year follow-up study of stroke in a Japanese provincial city. The Shibata Study. Stroke 28 (1997) 45-52
21. Kitamura A., Shimamoto T., Doi M., et al. Secular trends in prevalence and incidence of atrial fibrillation and associated factors in a Japanese rural population. Jpn J Public Health 38 (1991) 98-105 (Japanese with English abstract)
22. Ohsawa M., Okayama A., Sakata K., et al. Rapid increase in estimated number of persons with atrial fibrillation in Japan: an analysis from national surveys on cardiovascular diseases in 1980,1990 and 2000. J Epidemiol 15 (2005) 194-196
23. Japanese Registry of Residents in 2005. The Ministry of Internal Affairs and Communications, Japan. Statistics Bureau. (in Japanese). http://www.soumu.go.jp/s-news/2005/050727_3.html
24. Population Projection for Japan. National Institute of Population and Social Security Research, Japan. (in Japanese). http://www.jpss.go.jp
25. Lok N.S., and Lau C.P. Prevalence of palpitations, cardiac arrhythmias and their associated risk factors in ambulant elderly. Int J Cardiol 54 (1996) 231-236
26. Miyasaka Y., Barnes M.E., Gersh B.J., et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114 (2006) 119-125
27. Hurley V., Ireson R., Fletcher K., Lip G.Y.P., Hobbs F.D.R., and Mant J on behalf of the BAFTA Investigators. A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial. Int J Cardiol 117 (2007) 152-156
28. Ohsawa M., et al., for the NIPPON DATA80 Research Group. Mortality risk attributable to atrial fibrillation in middle-aged and elderly people in the Japanese general population - nineteen-year follow-up in NIPPON DATA80 -. Circ J 71 (2007) 814-819
29. Kannel W.B., Abbott R.D., Savage D.D., and McNamara P.M. Coronary heart disease and atrial fibrillation: the Framingham Study. Am Heart J 106 (1983) 389-396
30. Tomita F., et al., for the Hokkaido Atrial Fibrillation Study Group. Prevalence and clinical characteristics of patients with atrial fibrillation. Analysis of 20,000 cases in Japan. Jpn Circ J 64 (2000) 653-659
31. The AFFIRM Investigators. Baseline characteristics of patients with atrial fibrillation: the AFFIRM Study. Am Heart J 143 (2002) 991-1001
32. Lip G.Y.H., and Varughese G.I. Diabetes mellitus and atrial fibrillation: perspectives on epidemiological and pathophysiological links. Int J Cardiol 105 (2005) 319-321
33. The Ministry of Health, Labor and Welfare, Japan. Statistical database. (in Japanese). http://www1.mhlw.go.jp/toukei/h10-ktyosa/1-2-9_8.html
34. Watanabe E., Kuno Y., Takasuga H., et al. Seasonal variation in paroxysmal atrial fibrillation documented by 24-hour Holter electrocardiogram. Heart Rhythm 4 (2007) 27-31
35. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150